Clayton Damme, MD
Interventional Pain Medicine · Lincoln, NENPI 1225558448
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (47.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Nevro Corp. at 37.0% of the total. Reporting peaked in 2021 at $7,370 and has fallen 83.7% since, to $1,205 in 2025.
Across 218 payments — averaging $95.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$8K
- Medtronic$7K
- Abbott$2K
- Relievant Medsystems, Inc.$1K
- AbbVie$727
- Globus Medical$334
- plus $2K from 24 others
Across 2 payments — averaging $5549.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Nevro Corp.$11K
What the payments were for
- Grants$10,00048%
- Travel & lodging$4,12220%
- Food & beverage$5,79128%
- Education$1,0065%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 30 | $7,746 |
| Medtronic | 26 | $7,127 |
| Abbott | 20 | $1,525 |
| Relievant Medsystems, Inc. | 11 | $1,244 |
| AbbVie | 37 | $727 |
| Globus Medical | 4 | $334 |
| Lundbeck LLC | 10 | $305 |
| Pfizer | 15 | $280 |
| SPR Therapeutics, Inc | 7 | $277 |
| Boston Scientific | 5 | $231 |
| Collegium Pharmaceutical, Inc. | 11 | $189 |
| Lilly USA, LLC | 12 | $167 |
| Si-bone, Inc. | 3 | $165 |
| GRT US Holding, Inc. | 2 | $82 |
| Nalu Medical, Inc. | 4 | $78 |
| Stimwave Technologies Incorporated | 1 | $68 |
| MML US, Inc. | 3 | $49 |
| Vertex | 2 | $42 |
| Forte Bio-pharma LLC | 2 | $38 |
| Amgen | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Cerapedics Inc. | 1 | $25 |
| DJO, LLC | 1 | $22 |
| Vertos Medical, Inc. | 1 | $21 |
| Scilex Pharmaceuticals Inc. | 1 | $21 |
| Averitas Pharma Inc. | 1 | $21 |
| Impel Pharmaceuticals Inc. | 1 | $19 |
| Protega Pharmaceutials Inc | 1 | $18 |
| Fidia Pharma USA Inc. | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza Spinal Cord Stimulation System$5,000
- SYNCHROMED$5,000
- Intracept$2,263
- Senza$2,238
- PROCLAIM$1,085
- KYPHON Balloon Kyphoplasty$1,020
- RESTORE$400
- INTELLIS$141
- VYEPTI$117
How this compares
Too few interventional pain medicine providers in Nebraskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 24 | $4,070 |
| Duloxetine Hcl | 100 | $2,011 |
| Gabapentin | 84 | $1,310 |
| Pregabalin | 70 | $920 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $666 |
| Tizanidine Hcl | 21 | $202 |
| Tramadol Hcl | 45 | $138 |
| Meloxicam | 20 | $58 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Lincoln
- Kelly ZachLincoln$15K
- Soubrata RaikarFremont$38K
- Pravardhan BirthiGrand Island$19K
- Thomas BrooksElkhorn$13K
- Rafal KrejzaOmaha$13K
- Jery InbarasuOmaha$12K
- Kevin BalterOmaha$11K
- Madhuri AreOmaha$904
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.